These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 13341385)
1. [Contribution to the psychopathological study of the effects of lysergic acid monoethylamide]. CALLIERI B; RAVETTA M Arch Psicol Neurol Psichiatr; 1956; 17(1):43-79. PubMed ID: 13341385 [No Abstract] [Full Text] [Related]
2. [Psychological effects of lysergic acid monoethylamide (LAE 32)]. TONINI G; MONTANARI C G Psichiatr Neuropatol; 1955; 83(2):355-7. PubMed ID: 13251531 [No Abstract] [Full Text] [Related]
3. [Hallucinations caused by lysergic acid in bilateral enucleation]. ALEMA G Riv Neurol; 1952; 22(5):720-33. PubMed ID: 13056494 [No Abstract] [Full Text] [Related]
4. [Effects of diethylamide of lysergic acid on the psychic symptoms of schizophrenia; psychopathological study]. CALLIERI B; RAVETTA M Rass Studi Psichiatr; 1955; 44(1):39-88. PubMed ID: 13246040 [No Abstract] [Full Text] [Related]
5. [Body scheme disorders in lysergic acid diethylamide]. ARNOLD OH; HOFF H Wien Z Nervenheilkd Grenzgeb; 1953; 6(4):259-74. PubMed ID: 13078611 [No Abstract] [Full Text] [Related]
6. Model psychoses induced by LSD-25 in normals. II. Rorschach test findings. BERCEL NA; TRAVIS LE; OLINGER LB; DREIKURS E AMA Arch Neurol Psychiatry; 1956 Jun; 75(6):612-8. PubMed ID: 13325990 [No Abstract] [Full Text] [Related]
7. Model psychoses induced by LSD-25 in normals. I. Psychophysiological investigations, with special reference to the mechanism of the paranoid reaction. BERCEL NA; TRAVIS LE; OLINGER LB; DREIKURS E AMA Arch Neurol Psychiatry; 1956 Jun; 75(6):588-611. PubMed ID: 13325989 [No Abstract] [Full Text] [Related]
14. Role of 5-hydroxytryptamine in mental diseases and its antagonism to lysergic acid derivatives. CERLETTI A; ROTHLIN E Nature; 1955 Oct; 176(4486):785-6. PubMed ID: 13265830 [No Abstract] [Full Text] [Related]
15. Atrio-ventricular block after gynergen. BRODWALL EK Acta Med Scand; 1956 Jun; 154(5):387-90. PubMed ID: 13326281 [No Abstract] [Full Text] [Related]
16. [Lysergic acid ethylamide, a new ergot drug strongly sedative effect causing psychotic states]. SOLMS H Schweiz Med Wochenschr; 1953 Apr; 83(15):356-60. PubMed ID: 13076048 [No Abstract] [Full Text] [Related]
17. [Severe shock during hysterotomy in possible relation to an intravenous injection of methyl-ergobasine]. LYONNET R; BLANC PM Bull Fed Soc Gynecol Obstet Lang Fr; 1954; 6(5):650-1. PubMed ID: 13342613 [No Abstract] [Full Text] [Related]
18. [D-lysergic acid diethylamine and psychic disorders in ergotism]. DELAY J; PICHOT P C R Seances Soc Biol Fil; 1951 Nov; 145(21-22):1609-10. PubMed ID: 14926207 [No Abstract] [Full Text] [Related]
19. New blocking agent against the development of LSD-25 psychosis. FABING HD Science; 1955 Feb; 121(3137):208-10. PubMed ID: 13237971 [No Abstract] [Full Text] [Related]
20. Hallucinogenic drugs. COOPER HA Lancet; 1955 May; 268(6873):1078-9. PubMed ID: 14368965 [No Abstract] [Full Text] [Related] [Next] [New Search]